| Phase IV Interchangeability Study of a Liquid Pentavalent Combination Vaccine (NCT00674908) | Shantha Biotechnics Limited | 2008-03-01 |
| Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants (NCT00619502) | Sanofi Pasteur, a Sanofi Company | 2007-12-01 |
| Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants (NCT00514709) | Sanofi Pasteur, a Sanofi Company | 2007-09-01 |
| Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™ (NCT00534833) | Sanofi Pasteur, a Sanofi Company | 2007-09-01 |
| A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents (NCT00518180) | Novartis Vaccines | 2007-07-01 |
| Vanderbilt Pertussis Exposure Study: PEP in Vaccinated Healthcare Workers Following Pertussis Exposure (NCT00469274) | Vanderbilt University | 2007-05-01 |
| Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine (NCT00514059) | Norwegian Institute of Public Health | 2007-04-01 |
| Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age (NCT00467519) | Sanofi Pasteur, a Sanofi Company | 2007-04-01 |
| Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease (NCT00932269) | Swedish Institute for Infectious Disease Control | 2007-03-01 |
| A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older (NCT00457249) | Sanofi | 2007-03-01 |
| Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months (NCT00453570) | Sanofi | 2007-03-01 |
| Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) (NCT00432042) | Merck Sharp & Dohme LLC | 2007-01-12 |
| Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants (NCT00404651) | Sanofi Pasteur, a Sanofi Company | 2006-11-01 |
| Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® (NCT00355121) | Sanofi | 2006-10-01 |
| Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants (NCT00401531) | Sanofi Pasteur, a Sanofi Company | 2006-10-01 |
| Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV (NCT00362336) | Sanofi Pasteur, a Sanofi Company | 2006-08-01 |
| Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine (NCT00343889) | Sanofi Pasteur, a Sanofi Company | 2006-08-01 |
| Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® (NCT00362427) | Sanofi Pasteur, a Sanofi Company | 2006-08-01 |
| Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® Vaccine (NCT00347958) | Sanofi Pasteur, a Sanofi Company | 2006-08-01 |
| Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule (NCT00315055) | Sanofi Pasteur, a Sanofi Company | 2006-07-01 |
| Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers (NCT00343421) | Sanofi Pasteur, a Sanofi Company | 2006-07-01 |
| Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months. (NCT00313911) | Sanofi Pasteur, a Sanofi Company | 2006-07-01 |
| The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients (NCT00336115) | Queen Elizabeth II Health Sciences Centre | 2006-07-01 |
| Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants (NCT00348881) | Sanofi Pasteur, a Sanofi Company | 2006-06-01 |
| Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX® (NCT00319553) | Sanofi | 2006-05-01 |
| Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV (NCT00319852) | Sanofi | 2006-04-01 |
| Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine (NCT00304265) | Sanofi Pasteur, a Sanofi Company | 2006-03-01 |
| Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants (NCT00287092) | Sanofi Pasteur, a Sanofi Company | 2006-02-01 |
| Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants (NCT00303316) | Sanofi | 2006-02-01 |
| Immunogenicity and Safety of Pentaxim™ in an Indian Population (NCT00259337) | Sanofi | 2006-02-01 |
| Immunology of Non-specific Effects of Vaccine (NCT00168545) | Bandim Health Project | 2006-01-01 |
| Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine (NCT00258882) | Sanofi Pasteur, a Sanofi Company | 2006-01-01 |
| Pentavalent DTaP-Hep B-IPV (NCT00133445) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-01 |
| Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand (NCT00255021) | Sanofi | 2005-12-01 |
| Safety and Immune Response of Different Pediatric Combination Vaccines. (NCT00255047) | Sanofi Pasteur, a Sanofi Company | 2005-11-01 |
| Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan (NCT00258908) | Sanofi Pasteur, a Sanofi Company | 2005-11-01 |
| Immunogenicity and Safety of Pentaxim in South African Infants (NCT00254969) | Sanofi | 2005-10-01 |
| Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine (NCT00777257) | Sanofi Pasteur, a Sanofi Company | 2005-04-01 |
| Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL® (NCT00258895) | Sanofi Pasteur, a Sanofi Company | 2005-03-01 |
| Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths (NCT00158808) | GlaxoSmithKline | 2005-01-01 |
| Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants (NCT00831311) | Sanofi Pasteur, a Sanofi Company | 2004-10-01 |
| Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age (NCT00524732) | Sanofi Pasteur, a Sanofi Company | 2004-09-01 |
| Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™ (NCT00802867) | Sanofi Pasteur, a Sanofi Company | 2004-02-01 |
| Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines (NCT00254917) | Sanofi | 2003-10-01 |
| Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ (NCT00772928) | Sanofi | 2003-10-01 |
| Retrospective Survey of Safety of Fourth Dose Pentacel® in Children (NCT00772369) | Sanofi Pasteur, a Sanofi Company | 2003-09-01 |
| Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants (NCT00291967) | GlaxoSmithKline | 2002-11-01 |
| Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) (NCT00092469) | Merck Sharp & Dohme LLC | 2002-03-01 |
| Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately (NCT01457508) | GlaxoSmithKline | 1999-01-01 |
| Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly (NCT01457495) | GlaxoSmithKline | 1998-09-01 |
| Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults (NCT01267058) | GlaxoSmithKline | 1997-09-01 |
| Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection (NCT00004422) | IWK Health Centre | 1997-08-01 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines (NCT00004800) | National Institute of Allergy and Infectious Diseases (NIAID) | 1992-09-01 |
| Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines (NCT00004799) | National Institute of Allergy and Infectious Diseases (NIAID) | 1991-04-01 |
| Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs (NCT00013871) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Pilot Study Freeze and Transport Immune Cells (NCT00138268) | National Institute of Allergy and Infectious Diseases (NIAID) | |